Literature DB >> 10360221

Genomic analysis of the thymine-DNA glycosylase (TDG) gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma.

T Yatsuoka1, T Furukawa, T Abe, T Yokoyama, M Sunamura, M Kobari, S Matsuno, A Horii.   

Abstract

CONCLUSION: Abnormality of the thymine-DNA glycosylase (TDG) gene on 12q22-q24.1 appears to play a limited role in pancreatic ductal carcinogenesis.
BACKGROUND: Recently, a human G/T-specific TDG gene was identified. This protein acts in a system correcting G/T mispairs to G/C pairs. TDG was mapped to chromosome bands 12q22-q24.1, one of the regions frequently lost in pancreatic cancer. Therefore, there is the possibility that the TDG gene on 12q is one of the genes responsible for pancreatic ductal carcinogenesis.
METHODS: Nucleotide sequences of the entire coding region of the TDG gene were analyzed in 21 human pancreatic cancer cell lines. mRNA expression of the TDG gene was also analyzed by Northern hybridization in several human tissues and 21 human pancreatic cancer cell lines.
RESULTS: Decreased levels of mRNA expression were detected in the pancreatic cancer cell lines, but no somatic mutations were observed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10360221     DOI: 10.1385/IJGC:25:2:97

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  33 in total

1.  Localization and polymorphism of a chromosome 12-specific alpha satellite DNA sequence.

Authors:  L H Looijenga; V T Smit; J W Wessels; P Mollevanger; J W Oosterhuis; C J Cornelisse; P Devilee
Journal:  Cytogenet Cell Genet       Date:  1990

2.  Identification of a 790-kilobase region of common allelic loss in chromosome 10q25-q26 in human endometrial cancer.

Authors:  S Nagase; H Yamakawa; S Sato; A Yajima; A Horii
Journal:  Cancer Res       Date:  1997-05-01       Impact factor: 12.701

3.  Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas.

Authors:  M Schutte; R H Hruban; J Geradts; R Maynard; W Hilgers; S K Rabindran; C A Moskaluk; S A Hahn; I Schwarte-Waldhoff; W Schmiegel; S B Baylin; S E Kern; J G Herman
Journal:  Cancer Res       Date:  1997-08-01       Impact factor: 12.701

4.  Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase.

Authors:  P Neddermann; P Gallinari; T Lettieri; D Schmid; O Truong; J J Hsuan; K Wiebauer; J Jiricny
Journal:  J Biol Chem       Date:  1996-05-31       Impact factor: 5.157

5.  Stability of ras oncogene mutation in the human tumor xenografts through serial passages.

Authors:  H Kijima; Y Abe; H Yamazaki; Y Ohnishi; Y Ueyama; N Tamaoki; M Nakamura
Journal:  Anticancer Res       Date:  1994 Nov-Dec       Impact factor: 2.480

6.  Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.

Authors:  H J Han; A Yanagisawa; Y Kato; J G Park; Y Nakamura
Journal:  Cancer Res       Date:  1993-11-01       Impact factor: 12.701

7.  Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer.

Authors:  T Furukawa; T Yatsuoka; E M Youssef; T Abe; T Yokoyama; S Fukushige; E Soeda; M Hoshi; Y Hayashi; M Sunamura; M Kobari; A Horii
Journal:  Cytogenet Cell Genet       Date:  1998

8.  Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen.

Authors:  T Kishimoto; H Ishikura; C Kimura; T Takahashi; H Kato; T Yoshiki
Journal:  Int J Cancer       Date:  1996-08-22       Impact factor: 7.396

Review 9.  Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.

Authors:  M S Greenblatt; W P Bennett; M Hollstein; C C Harris
Journal:  Cancer Res       Date:  1994-09-15       Impact factor: 12.701

10.  Autonomous production of granulocyte-colony stimulating factor in tumour xenografts associated with leukocytosis.

Authors:  Y Katoh; M Nakamura; Y Ohnishi; K Shimamura; Y Ueyama; N Tamaoki
Journal:  Br J Cancer       Date:  1993-10       Impact factor: 7.640

View more
  8 in total

1.  DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.

Authors:  F P Fortes; H Kuasne; F A Marchi; P M Miranda; S R Rogatto; M I Achatz
Journal:  Braz J Med Biol Res       Date:  2015-04-28       Impact factor: 2.590

Review 2.  Multifaceted roles for thymine DNA glycosylase in embryonic development and human carcinogenesis.

Authors:  Xuehe Xu; David S Watt; Chunming Liu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2015-09-14       Impact factor: 3.848

3.  Loss of heterozygosity occurs predominantly, but not exclusively, in the epithelial compartment of pleomorphic adenoma.

Authors:  Micaela Poetsch; Anett Zimmermann; Eduard Wolf; Britta Kleist
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

4.  Regions of allelic imbalance in the distal portion of chromosome 12q in gastric cancer.

Authors:  B G Schneider; S Y Rha; H C Chung; J C Bravo; R Mera; J C Torres; K T Plaisance; R Schlegel; C M McBride; X T Reveles; R J Leach
Journal:  Mol Pathol       Date:  2003-06

Review 5.  DNA demethylation by TDG.

Authors:  Shannon R Dalton; Alfonso Bellacosa
Journal:  Epigenomics       Date:  2012-08       Impact factor: 4.778

6.  TDG suppresses the migration and invasion of human colon cancer cells via the DNMT3A/TIMP2 axis.

Authors:  Jiyu Miao; Changan Zhao; Kaijie Tang; Xiaofan Xiong; Fei Wu; Wanjuan Xue; Baojun Duan; Huahua Zhang; Xintao Jing; Wen Li; Ying Sun; Ni Hou; Chen Huang
Journal:  Int J Biol Sci       Date:  2022-03-21       Impact factor: 6.580

7.  Oncogenic Ras suppresses ING4-TDG-Fas axis to promote apoptosis resistance.

Authors:  Jie Sun; Qi Shen; Haiqi Lu; Zhinong Jiang; Wenxia Xu; Lifeng Feng; Ling Li; Xian Wang; Xiujun Cai; Hongchuan Jin
Journal:  Oncotarget       Date:  2015-12-08

8.  Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas.

Authors:  Jeremy T-H Chang; Fan Wang; William Chapin; R Stephanie Huang
Journal:  PLoS One       Date:  2016-12-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.